Literature DB >> 22608396

The diagnostic value of dynamic contrast-enhanced MRI for thyroid tumors.

Ying Yuan1, Xiu-Hui Yue, Xiao-Feng Tao.   

Abstract

BACKGROUND AND
PURPOSE: The exact place for dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in the diagnosis and management of thyroid tumors is still under debate. We performed the study to analyze and compare the parameters generated from DCE-MRI for thyroid lesions.
MATERIALS AND METHODS: For each thyroid lesion, time intensity curves (TIC), time of peak enhancement (Tpeak), maximum enhancement ratio (ERmax) and maximum rise slope (Slopemax) were plotted and calculated. Receiver operator characteristics (ROC) analysis was conducted to assess the diagnostic ability and appropriate cut-off value. The area under the ROC curve (AUC) and the confidence intervals (CIs) were also assessed.
RESULTS: Forty-two patients were consecutively included. All 21 lesions demonstrated the rapid inflow and washout pattern (type-I) were benign. The 12 cases with delayed inflow pattern (type-III) were all malignant. When compared with the benign lesions, the thyroid carcinoma showed significantly lower Slopemax and higher Tpeak (P<0.05). No statistical difference of ERmax was found between malignant and benign ones (P=0.15). The AUC of ERmax, Slopemax and Tpeak in differentiating benign thyroid lesions from malignant ones were 0.63, 0.93 and 1, respectively. The ERmax cut-off value of 73.86 (sensitivity, 71.4%; specificity, 64.3%), Slopemax cut-off value of 2.4126 (sensitivity, 92.9%; specificity, 82.1%) and Tpeak value of 28 (sensitivity, 100%; specificity, 100%) offered the best diagnostic performances.
CONCLUSIONS: DCE-MRI, especially the pattern of TIC and the value of Slopemax and Tpeak, could be helpful in differentiating thyroid carcinoma from benign thyroid lesions.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22608396     DOI: 10.1016/j.ejrad.2012.04.029

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  14 in total

1.  Differential diagnostic value of diffusion-weighted and dynamic contrast-enhanced MR imaging in non-cystic lesions in floor of the mouth.

Authors:  Ying Yuan; Mengda Jiang; Lizhong Wu; Xiaofeng Tao
Journal:  Dentomaxillofac Radiol       Date:  2018-11-30       Impact factor: 2.419

2.  The Use of Dynamic Contrast-Enhanced Perfusion MRI in Differentiating Benign and Malignant Thyroid Nodules.

Authors:  Muhammed Sedat Sakat; Recep Sade; Korhan Kilic; Mustafa Sıtkı Gözeler; Osman Pala; Gökhan Polat; Mecit Kantarcı
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-10-15

3.  Dynamic Contrast-Enhanced MRI Parameters as Biomarkers in Assessing Head and Neck Lesions After Chemoradiotherapy Using a Wide-Bore 3 Tesla Scanner.

Authors:  Gergely Lerant; Peter Sarkozy; Zoltan Takacsi-Nagy; Gabor Polony; Laszlo Tamas; Erika Toth; Andras Boer; Laszlo Javor; Maria Godeny
Journal:  Pathol Oncol Res       Date:  2015-04-30       Impact factor: 3.201

Review 4.  Dynamic Contrast-Enhanced MR Imaging in Head and Neck Cancer: Techniques and Clinical Applications.

Authors:  S Gaddikeri; R S Gaddikeri; T Tailor; Y Anzai
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-01       Impact factor: 3.825

5.  Parotid gland lesions: separate and combined diagnostic value of conventional MRI, diffusion-weighted imaging and dynamic contrast-enhanced MRI.

Authors:  Ying Yuan; Weiqing Tang; Xiaofeng Tao
Journal:  Br J Radiol       Date:  2016-02-19       Impact factor: 3.039

6.  Dynamic contrast-enhanced MRI model selection for predicting tumor aggressiveness in papillary thyroid cancers.

Authors:  Ramesh Paudyal; Yonggang Lu; Vaios Hatzoglou; Andre Moreira; Hilda E Stambuk; Jung Hun Oh; Kristen M Cunanan; David Aramburu Nunez; Yousef Mazaheri; Mithat Gonen; Alan Ho; James A Fagin; Richard J Wong; Ashok Shaha; R Michael Tuttle; Amita Shukla-Dave
Journal:  NMR Biomed       Date:  2019-11-04       Impact factor: 4.044

7.  (99m)Tc-labeled-rhTSH analogue (TR1401) for imaging poorly differentiated metastatic thyroid cancer.

Authors:  Filippo Galli; Isabella Manni; Giulia Piaggio; Lajos Balogh; Bruce D Weintraub; Mariusz W Szkudlinski; Valerie Fremont; Rudi A J O Dierckx; Alberto Signore
Journal:  Thyroid       Date:  2014-06-20       Impact factor: 6.568

8.  Golden-Angle Radial Sparse Parallel (GRASP) MRI differentiates head & neck paragangliomas from schwannomas.

Authors:  T Demerath; K Blackham; C Anastasopoulos; K T Block; B Stieltjes; T Schubert
Journal:  Magn Reson Imaging       Date:  2020-04-23       Impact factor: 2.546

9.  Dynamic contrast-enhanced magnetic resonance imaging for pretreatment prediction of early chemo-radiotherapy response in larynx and hypopharynx carcinoma.

Authors:  Wei Guo; Dehong Luo; Xinyi Chen; Meng Lin; Lin Li; Yanfeng Zhao; Liang Yang; Lei Hu; Xinming Zhao; Chunwu Zhou
Journal:  Oncotarget       Date:  2017-05-16

10.  Head and neck paragangliomas: diffusion weighted and dynamic contrast enhanced magnetic resonance imaging characteristics.

Authors:  Ying Yuan; Huimin Shi; Xiaofeng Tao
Journal:  BMC Med Imaging       Date:  2016-02-01       Impact factor: 1.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.